Notable examples include the presence of mutated KRAS, which has been associated with an unfavorable prognosis in pancreatic [33] and lung cancer [34], as well as the presence of mutated NRAS, which has been related to a poor prognosis in metastatic melanoma [35]. The gene discussed is KRAS; the disease is metastatic melanoma.